USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Valuation

NYSE:USNA • US90328M1071

Current stock price

16.91 USD
-0.23 (-1.34%)
At close:
16.91 USD
0 (0%)
After Hours:

This USNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. USNA Profitability Analysis

1.1 Basic Checks

  • USNA had positive earnings in the past year.
  • USNA had a positive operating cash flow in the past year.
  • USNA had positive earnings in each of the past 5 years.
  • Of the past 5 years USNA 4 years had a positive operating cash flow.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.34%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
  • With a decent Return On Equity value of 3.22%, USNA is doing good in the industry, outperforming 67.57% of the companies in the same industry.
  • USNA's Return On Invested Capital of 5.43% is in line compared to the rest of the industry. USNA outperforms 59.46% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.44%.
  • The 3 year average ROIC (9.82%) for USNA is well above the current ROIC(5.43%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROIC 5.43%
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.86%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
  • In the last couple of years the Profit Margin of USNA has declined.
  • Looking at the Operating Margin, with a value of 4.58%, USNA is in line with its industry, outperforming 56.76% of the companies in the same industry.
  • USNA's Operating Margin has declined in the last couple of years.
  • The Gross Margin of USNA (79.18%) is better than 94.59% of its industry peers.
  • In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
Industry RankSector Rank
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. USNA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
  • USNA has less shares outstanding than it did 1 year ago.
  • USNA has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, USNA has an improved debt to assets ratio.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • USNA has an Altman-Z score of 3.52. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.52, USNA is doing good in the industry, outperforming 75.68% of the companies in the same industry.
  • There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACC0.62
WACC8.71%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • USNA has a Current Ratio of 2.23. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
  • USNA's Current ratio of 2.23 is in line compared to the rest of the industry. USNA outperforms 59.46% of its industry peers.
  • A Quick Ratio of 1.46 indicates that USNA should not have too much problems paying its short term obligations.
  • USNA has a better Quick ratio (1.46) than 62.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.46
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. USNA Growth Analysis

3.1 Past

  • The earnings per share for USNA have decreased strongly by -26.15% in the last year.
  • USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.00% yearly.
  • The Revenue has grown by 8.28% in the past year. This is quite good.
  • The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%

3.2 Future

  • USNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.31% yearly.
  • The Revenue is expected to grow by 4.02% on average over the next years.
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. USNA Valuation Analysis

4.1 Price/Earnings Ratio

  • USNA is valuated reasonably with a Price/Earnings ratio of 8.81.
  • USNA's Price/Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 81.08% of the companies in the same industry.
  • USNA is valuated cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • USNA is valuated reasonably with a Price/Forward Earnings ratio of 8.29.
  • USNA's Price/Forward Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 83.78% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, USNA is valued rather cheaply.
Industry RankSector Rank
PE 8.81
Fwd PE 8.29
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaper than 97.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.56
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • USNA's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y21.31%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USNA Dividend Analysis

5.1 Amount

  • USNA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USNA Fundamentals: All Metrics, Ratios and Statistics

USANA HEALTH SCIENCES INC

NYSE:USNA (3/20/2026, 8:26:43 PM)

After market: 16.91 0 (0%)

16.91

-0.23 (-1.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17
Earnings (Next)04-20
Inst Owners58.34%
Inst Owner Change0.34%
Ins Owners0.65%
Ins Owner Change0.54%
Market Cap309.11M
Revenue(TTM)925.26M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (135.25%)
Short Float %3.88%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)2.56%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)4.38%
Valuation
Industry RankSector Rank
PE 8.81
Fwd PE 8.29
P/S 0.34
P/FCF N/A
P/OCF 9.81
P/B 0.59
P/tB 1.26
EV/EBITDA 2.56
EPS(TTM)1.92
EY11.35%
EPS(NY)2.04
Fwd EY12.06%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY10.2%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)1.41
PEG (5Y)N/A
Graham Number35.33
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROCE 6.88%
ROIC 5.43%
ROICexc 7.14%
ROICexgc 18.34%
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
FCFM N/A
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 973.94%
Cap/Sales 23.69%
Interest Coverage 62.89
Cash Conversion 49.24%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.46
Altman-Z 3.52
F-Score7
WACC8.71%
ROIC/WACC0.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year32.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-381.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.2%
OCF growth 3YN/A
OCF growth 5YN/A

USANA HEALTH SCIENCES INC / USNA Fundamental Analysis FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 5 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.


Can you provide the profitability details for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 5 / 10.


What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?

The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 8 / 10.


Can you provide the expected EPS growth for USNA stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 6.25% in the next year.